Literature DB >> 26742534

Preoperative curves of greater magnitude (>70°) in adolescent idiopathic scoliosis are associated with increased surgical complexity, higher cost of surgical treatment and a delayed return to function.

R C Tarrant1,2, J M Queally3, P F O'Loughlin3, P Sheeran4,5, D P Moore3,5, P J Kiely3,5.   

Abstract

BACKGROUND: Surgical procedures to correct larger curve magnitudes >70° in patients with adolescent idiopathic scoliosis (AIS) are still common; despite their increased complexity, limited research has assessed the effect of preoperative curve severity on outcomes. AIM: This study aimed to examine the impact of preoperative curves >70° vs. those ≤70° on perioperative, functional and financial outcomes in patients with AIS undergoing posterior spinal fusion (PSF).
METHODS: Seventy seven eligible AIS patients who underwent PSF were prospectively followed-up, until return to preoperative function was reported. Preoperative curves >70° vs. ≤70° were analysed in relation to surgical duration, estimated blood loss, perioperative complications, length of hospitalisation, return to function and cost of surgical treatment per patient.
RESULTS: Severe preoperative curves >70°, identified in 21 patients (27.3 %), were associated with significantly longer surgical duration (median 6.5 vs. 5 h, p = 0.001) and increased blood loss (median 1250 vs. 1000 ml, p = 0.005)-these patients were 2.1 times more likely to receive a perioperative blood product transfusion (Relative Risk 2.1, CI 1.4-2.7, p = 0.004). Curves >70° were also associated with a significantly delayed return to school/college, and an increased cost of surgical treatment (€33,730 vs. €28,620, p < 0.0001).
CONCLUSION: Surgeons can expect a longer surgical duration, greater intraoperative blood loss and double the blood product transfusion risk when performing PSF procedures on AIS patients with curves greater than 70° vs. those ≤70°. Surgical correction for curves >70°, often as a result of lengthy surgical waiting lists, also incurs added expense and results in a partial delay in early functional recovery.

Entities:  

Keywords:  Adolescent idiopathic scoliosis; Cost of surgical treatment; Functional outcomes; Large deformity magnitude; Perioperative outcomes; Posterior spinal fusion; Surgical waiting times

Mesh:

Year:  2016        PMID: 26742534     DOI: 10.1007/s11845-015-1391-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  24 in total

1.  Accuracy and efficacy of thoracic pedicle screws in curves more than 90 degrees.

Authors:  Timothy R Kuklo; Lawrence G Lenke; Michael F O'Brien; Ronald A Lehman; David W Polly; Teresa M Schroeder
Journal:  Spine (Phila Pa 1976)       Date:  2005-01-15       Impact factor: 3.468

2.  Treatment of idiopathic scoliosis exceeding 100 degrees - comparison of different surgical techniques.

Authors:  Tomasz Potaczek; Barbara Jasiewicz; Maciej Tesiorowski; Daniel Zarzycki; Andrzej Szcześniak
Journal:  Ortop Traumatol Rehabil       Date:  2009 Nov-Dec

3.  Hospital cost analysis of adolescent idiopathic scoliosis correction surgery in 125 consecutive cases.

Authors:  Jonathan R Kamerlink; Martin Quirno; Joshua D Auerbach; Andrew H Milby; Lynne Windsor; Laura Dean; Joseph W Dryer; Thomas J Errico; Baron S Lonner
Journal:  J Bone Joint Surg Am       Date:  2010-05       Impact factor: 5.284

4.  Height of girls with adolescent idiopathic scoliosis.

Authors:  Mauno Ylikoski
Journal:  Eur Spine J       Date:  2003-04-01       Impact factor: 3.134

5.  Timing and predictors of return to short-term functional activity in adolescent idiopathic scoliosis after posterior spinal fusion: a prospective study.

Authors:  Roslyn C Tarrant; Padhraig F OʼLoughlin; Sam Lynch; Joseph M Queally; Padraig Sheeran; David P Moore; Patrick J Kiely
Journal:  Spine (Phila Pa 1976)       Date:  2014-08-15       Impact factor: 3.468

6.  The treatment of large (>70 degrees) thoracic idiopathic scoliosis curves with posterior instrumentation and arthrodesis: when is anterior release indicated?

Authors:  Douglas C Burton; Andrew A Sama; Marc A Asher; Stephen W Burke; Oheneba Boachie-Adjei; R C Huang; D W Green; Bernard A Rawlins
Journal:  Spine (Phila Pa 1976)       Date:  2005-09-01       Impact factor: 3.468

7.  Empirically derived maximal acceptable wait time for surgery to treat adolescent idiopathic scoliosis.

Authors:  Henry Ahn; Hans Kreder; Nizar Mahomed; Dorcas Beaton; James G Wright
Journal:  CMAJ       Date:  2011-05-02       Impact factor: 8.262

8.  Impact of Surgical Waiting-List Times on Scoliosis Surgery: The Surgeon's Perspective.

Authors:  Firoz Miyanji; Peter O Newton; Amer F Samdani; Suken A Shah; Ranjit A Varghese; Christopher W Reilly; Kishore Mulpuri
Journal:  Spine (Phila Pa 1976)       Date:  2015-06-01       Impact factor: 3.468

Review 9.  Adolescent idiopathic scoliosis.

Authors:  Stuart L Weinstein; Lori A Dolan; Jack C Y Cheng; Aina Danielsson; Jose A Morcuende
Journal:  Lancet       Date:  2008-05-03       Impact factor: 79.321

10.  Anterior spinal fusion versus posterior spinal fusion for moderate lumbar/thoracolumbar adolescent idiopathic scoliosis: a prospective study.

Authors:  Yipeng Wang; Qi Fei; Guixing Qiu; Chia I Lee; Jianxiong Shen; Jianguo Zhang; Hong Zhao; Yu Zhao; Hai Wang; Suomao Yuan
Journal:  Spine (Phila Pa 1976)       Date:  2008-09-15       Impact factor: 3.468

View more
  2 in total

1.  Community Care Administration of Spinal Deformities in the Brazilian Public Health System.

Authors:  Mario Bressan-Neto; Carlos Fernando Pereira da Silva Herrero; Lilian Maria Pacola; Altacílio Aparecido Nunes; Helton Luiz Aparecido Defino
Journal:  Clinics (Sao Paulo)       Date:  2017-08       Impact factor: 2.365

2.  Severe Lenke 1 and 2 adolescent idiopathic scoliosis had poorer perioperative outcome, higher complication rate, longer fusion and higher operative cost compared to non-severe scoliosis.

Authors:  Weng Hong Chung; Yu Jie Lee; Chee Kidd Chiu; Mohd Shahnaz Hasan; Chris Yin Wei Chan; Mun Keong Kwan
Journal:  Eur Spine J       Date:  2022-01-23       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.